Martin Shkreli and the Crisis of Corporate Conscience
by Joe HeschmeyerA few months ago, BBC News suggested that “Martin Shkreli, the 32-year-old chief executive of Turing Pharmaceuticals, may be the most hated man in America right now.” That's because Turing, under Shkreli's watch, increased the price of a drug called Daraprim from $13.50 to $750 per tablet . . . . Continue Reading »